| Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate IA Siddiqui, VM Adhami, DJ Bharali, BB Hafeez, M Asim, SI Khwaja, ... Cancer research 69 (5), 1712-1716, 2009 | 420 | 2009 |
| Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer IA Siddiqui*, M Asim*(equal first), BB Hafeez, VM Adhami, RS Tarapore, ... The FASEB Journal 25 (4), 1198-1207, 2011 | 269 | 2011 |
| Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer M Asim (corresponding), F Tarish, HI Zecchini, K Sanjiv, E Gelali, ... Nature communications 8 (1), 1-10, 2017 | 251* | 2017 |
| Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and … IA Siddiqui, A Malik, VM Adhami, M Asim, BB Hafeez, S Sarfaraz, ... Oncogene 27 (14), 2055-2063, 2008 | 248 | 2008 |
| A dietary anthocyanidin delphinidin induces apoptosis of human prostate cancer PC3 cells in vitro and in vivo: involvement of nuclear factor-κB signaling BB Hafeez, IA Siddiqui, M Asim, A Malik, F Afaq, VM Adhami, M Saleem, ... Cancer research 68 (20), 8564-8572, 2008 | 247 | 2008 |
| A novel dietary flavonoid fisetin inhibits androgen receptor signaling and tumor growth in athymic nude mice N Khan*, M Asim* (equal first), F Afaq, MA Zaid, H Mukhtar Cancer research 68 (20), 8555-8563, 2008 | 186 | 2008 |
| Targeted Knockdown of Notch1 Inhibits Invasion of Human Prostate Cancer Cells Concomitant with Inhibition of Matrix Metalloproteinase-9 and Urokinase … B Bin Hafeez, VM Adhami, M Asim, IA Siddiqui, KM Bhat, W Zhong, ... Clinical cancer research 15 (2), 452-459, 2009 | 179 | 2009 |
| Lupeol Inhibits Growth of Highly Aggressive Human Metastatic Melanoma Cells In vitro and In vivo by Inducing Apoptosis M Saleem, N Maddodi, M Abu Zaid, N Khan, B bin Hafeez, M Asim, Y Suh, ... Clinical cancer research 14 (7), 2119-2127, 2008 | 170 | 2008 |
| A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy N Pertega‐Gomes, S Felisbino, CE Massie, JR Vizcaino, R Coelho, ... The Journal of pathology 236 (4), 517-530, 2015 | 147 | 2015 |
| Lupeol inhibits proliferation of human prostate cancer cells by targeting β-catenin signaling M Saleem, I Murtaza, RS Tarapore, Y Suh, VM Adhami, JJ Johnson, ... Carcinogenesis 30 (5), 808-817, 2009 | 121 | 2009 |
| Src kinase potentiates androgen receptor transactivation function and invasion of androgen-independent prostate cancer C4-2 cells M Asim, IA Siddiqui, BB Hafeez, A Baniahmad, H Mukhtar Oncogene 27 (25), 3596-3604, 2008 | 100 | 2008 |
| Suppression of NFκB and its regulated gene products by oral administration of green tea polyphenols in an autochthonous mouse prostate cancer model IA Siddiqui, Y Shukla, VM Adhami, S Sarfaraz, M Asim, BB Hafeez, ... Pharmaceutical research 25, 2135-2142, 2008 | 80 | 2008 |
| Delphinidin, a dietary anthocyanidin in pigmented fruits and vegetables: a new weapon to blunt prostate cancer growth B Bin Hafeez, M Asim, IA Siddiqui, VM Adhami, I Murtaza, H Mukhtar Cell cycle 7 (21), 3320-3326, 2008 | 72 | 2008 |
| Nuclear ARRB 1 induces pseudohypoxia and cellular metabolism reprogramming in prostate cancer V Zecchini, B Madhu, R Russell, N Pértega‐Gomes, A Warren, E Gaude, ... The EMBO journal 33 (12), 1365-1382, 2014 | 68 | 2014 |
| Wild‐type but not mutant androgen receptor inhibits expression of the hTERT telomerase subunit: a novel role of AR mutation for prostate cancer development U Moehren, M Papaioannou, CA Reeb, A Grasselli, S Nanni, M Asim, ... The FASEB Journal 22 (4), 1258-1267, 2008 | 66 | 2008 |
| BK Ca Channels Activating at Resting Potential without Calcium in LNCaP Prostate Cancer Cells G Gessner, K Schönherr, M Soom, A Hansel, M Asim, A Baniahmad, ... The Journal of membrane biology 208, 229-240, 2006 | 65 | 2006 |
| Tea beverage in chemoprevention and chemotherapy of prostate cancer IA Siddiqui, M Saleem, VM Adhami, M Asim, H Mukhtar Acta Pharmacologica Sinica 28 (9), 1392-1408, 2007 | 61 | 2007 |
| Choline kinase alpha as an androgen receptor chaperone and prostate cancer therapeutic target M Asim (corresponding), CE Massie, F Orafidiya, N Pértega-Gomes, ... Journal of the National Cancer Institute 108 (5), djv371, 2016 | 52 | 2016 |
| Differential C3NET reveals disease networks of direct physical interactions G Altay, M Asim, F Markowetz, DE Neal Bmc Bioinformatics 12, 1-12, 2011 | 48 | 2011 |
| Ligand-dependent corepressor acts as a novel androgen receptor corepressor, inhibits prostate cancer growth, and is functionally inactivated by the Src protein kinase M Asim, BB Hafeez, IA Siddiqui, C Gerlach, M Patz, H Mukhtar, ... Journal of Biological Chemistry 286 (43), 37108-37117, 2011 | 47 | 2011 |
